Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B0KP
|
|||
| Former ID |
DNC004660
|
|||
| Drug Name |
1-Oxazolo[4,5-b]pyridin-2-yl-octadec-9-yn-1-one
|
|||
| Synonyms |
1-oxazolo[4,5-b]pyridin-2-yl-9-octadecyn-1-one; 288862-89-5; CHEMBL175580; 1-Oxazolo[4,5-b]pyridin-2-yl-octadec-9-yn-1-one; SCHEMBL1811297; CTK8E3290; DTXSID50433602; HMS3649E20; BDBM50163152; ZINC34803574; ACM288862895; RT-006406; SR-01000946605; SR-01000946605-1; J-017317
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H34N2O2
|
|||
| Canonical SMILES |
CCCCCCCCC#CCCCCCCCC(=O)C1=NC2=C(O1)C=CC=N2
|
|||
| InChI |
1S/C24H34N2O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-18-21(27)24-26-23-22(28-24)19-17-20-25-23/h17,19-20H,2-8,11-16,18H2,1H3
|
|||
| InChIKey |
DBMKKVSGBYKSFI-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 288862-89-5
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as a... J Med Chem. 2005 Mar 24;48(6):1849-56. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.